Further studies are necessary to understand the mechanisms that underlie the downregulation of MARCH8 in HCC tissues and other potential regulatory pathways of SREBP1. The proposed approach may promote a comprehensive theoretical basis for targeting the MARCH8-SREBP1 molecule as a potential therapeutic strategy for HCC. The gene discussed is MARCHF8; the disease is hepatocellular carcinoma.